Top

Published in:

01-05-2012

Diabetic cardiomyopathy: understanding the molecular and cellular basis to progress in diagnosis and treatment

Authors: Inês Falcão-Pires, Adelino F. Leite-Moreira

Published in: Heart Failure Reviews | Issue 3/2012

Abstract

Diabetes mellitus is an important and prevalent risk factor for congestive heart failure. Diabetic cardiomyopathy has been defined as ventricular dysfunction that occurs in diabetic patients independent of a recognized cause such as coronary artery disease or hypertension. The disease course consists of a hidden subclinical period, during which cellular structural insults and abnormalities lead initially to diastolic dysfunction, later to systolic dysfunction, and eventually to heart failure. Left ventricular hypertrophy, metabolic abnormalities, extracellular matrix changes, small vessel disease, cardiac autonomic neuropathy, insulin resistance, oxidative stress, and apoptosis are the most important contributors to diabetic cardiomyopathy onset and progression. Hyperglycemia is a major etiological factor in the development of diabetic cardiomyopathy. It increases the levels of free fatty acids and growth factors and causes abnormalities in substrate supply and utilization, calcium homeostasis, and lipid metabolism. Furthermore, it promotes excessive production and release of reactive oxygen species, which induces oxidative stress leading to abnormal gene expression, faulty signal transduction, and cardiomyocytes apoptosis. Stimulation of connective tissue growth factor, fibrosis, and the formation of advanced glycation end-products increase the stiffness of the diabetic hearts. Despite all the current information on diabetic cardiomyopathy, translational research is still scarce due to limited human myocardial tissue and most of our knowledge is extrapolated from animals. This paper aims to elucidate some of the molecular and cellular pathophysiologic mechanisms, structural changes, and therapeutic strategies that may help struggle against diabetic cardiomyopathy.

Aasum E, Hafstad AD, Severson DL, Larsen TS (2003) Age-dependent changes in metabolism, contractile function, and ischemic sensitivity in hearts from db/db mice. Diabetes 52(2):434–441PubMedCrossRef

Abaci A, Oguzhan A, Kahraman S, Eryol NK, Unal S, Arinc H, Ergin A (1999) Effect of diabetes mellitus on formation of coronary collateral vessels. Circulation 99(17):2239–2242PubMed

Abe T, Ohga Y, Tabayashi N, Kobayashi S, Sakata S, Misawa H, Tsuji T, Kohzuki H, Suga H, Taniguchi S, Takaki M (2002) Left ventricular diastolic dysfunction in type 2 diabetes mellitus model rats. Am J Physiol Heart Circ Physiol 282(1):H138–H148PubMed

Afzal N, Ganguly PK, Dhalla KS, Pierce GN, Singal PK, Dhalla NS (1988) Beneficial effects of verapamil in diabetic cardiomyopathy. Diabetes 37(7):936–942PubMedCrossRef

Afzal N, Pierce GN, Elimban V, Beamish RE, Dhalla NS (1989) Influence of verapamil on some subcellular defects in diabetic cardiomyopathy. Am J Physiol 256(4 Pt 1):E453–458

Airaksinen J, Ikaheimo M, Kaila J, Linnaluoto M, Takkunen J (1984) Impaired left ventricular filling in young female diabetics. An echocardiographic study. Acta Med Scand 216(5):509–516

Al-Shafei AI, Wise RG, Gresham GA, Bronns G, Carpenter TA, Hall LD, Huang CL (2002) Non-invasive magnetic resonance imaging assessment of myocardial changes and the effects of angiotensin-converting enzyme inhibition in diabetic rats. J Physiol 538(Pt 2):541–553PubMedCrossRef

Amato L, Paolisso G, Cacciatore F, Ferrara N, Ferrara P, Canonico S, Varricchio M, Rengo F (1997) Congestive heart failure predicts the development of non-insulin-dependent diabetes mellitus in the elderly. The osservatorio geriatrico regione campania group. Diabetes Metab 23(3):213–218

Aneja A, Tang WH, Bansilal S, Garcia MJ, Farkouh ME (2008) Diabetic cardiomyopathy: insights into pathogenesis, diagnostic challenges, and therapeutic options. Am J Med 121(9):748–757PubMedCrossRef

10.

Anversa P, Kajstura J (1998) Myocyte cell death in the diseased heart. Circ Res 82(11):1231–1233PubMed

11.

Anversa P, Leri A, Beltrami CA, Guerra S, Kajstura J (1998) Myocyte death and growth in the failing heart. Lab Invest 78(7):767–786PubMed

12.

Arikawa E, Ma RC, Isshiki K, Luptak I, He Z, Yasuda Y, Maeno Y, Patti ME, Weir GC, Harris RA, Zammit VA, Tian R, King GL (2007) Effects of insulin replacements, inhibitors of angiotensin, and pkcbeta’s actions to normalize cardiac gene expression and fuel metabolism in diabetic rats. Diabetes 56(5):1410–1420PubMedCrossRef

13.

Arnold JM, Yusuf S, Young J, Mathew J, Johnstone D, Avezum A, Lonn E, Pogue J, Bosch J (2003) Prevention of heart failure in patients in the heart outcomes prevention evaluation (hope) study. Circulation 107(9):1284–1290PubMedCrossRef

14.

Aronson D (2003) Cross-linking of glycated collagen in the pathogenesis of arterial and myocardial stiffening of aging and diabetes. J Hypertens 21(1):3–12PubMedCrossRef

15.

Arvan S, Singal K, Knapp R, Vagnucci A (1988) Subclinical left ventricular abnormalities in young diabetics. Chest 93(5):1031–1034PubMedCrossRef

16.

Astorri E, Fiorina P, Contini GA, Albertini D, Magnati G, Astorri A, Lanfredini M (1997) Isolated and preclinical impairment of left ventricular filling in insulin-dependent and non-insulin-dependent diabetic patients. Clin Cardiol 20(6):536–540PubMedCrossRef

17.

Baumann CA, Ribon V, Kanzaki M, Thurmond DC, Mora S, Shigematsu S, Bickel PE, Pessin JE, Saltiel AR (2000) Cap defines a second signalling pathway required for insulin-stimulated glucose transport. Nature 407(6801):202–207PubMedCrossRef

18.

Belcastro AN, Maybank P, Rossiter M, Secord D (1985) Effect of endurance swimming on rat cardiac myofibrillar atpase with experimental diabetes. Can J Physiol Pharmacol 63(9):1202–1205PubMedCrossRef

19.

Bell DS (2003) Diabetic cardiomyopathy. Diabetes Care 26(10):2949–2951PubMedCrossRef

20.

Bella JN, Devereux RB, Roman MJ, Palmieri V, Liu JE, Paranicas M, Welty TK, Lee ET, Fabsitz RR, Howard BV (2001) Separate and joint effects of systemic hypertension and diabetes mellitus on left ventricular structure and function in American Indians (the strong heart study). Am J Cardiol 87(11):1260–1265PubMedCrossRef

21.

Berg TJ, Snorgaard O, Faber J, Torjesen PA, Hildebrandt P, Mehlsen J, Hanssen KF (1999) Serum levels of advanced glycation end products are associated with left ventricular diastolic function in patients with type 1 diabetes. Diabetes Care 22(7):1186–1190PubMedCrossRef

22.

Berry C, Brett M, Stevenson K, McMurray JJ, Norrie J (2008) Nature and prognostic importance of abnormal glucose tolerance and diabetes in acute heart failure. Heart 94(3):296–304PubMedCrossRef

23.

Bertoni AG, Tsai A, Kasper EK, Brancati FL (2003) Diabetes and idiopathic cardiomyopathy: a nationwide case-control study. Diabetes Care 26(10):2791–2795PubMedCrossRef

24.

Bertoni AG, Hundley WG, Massing MW, Bonds DE, Burke GL, Goff DC Jr (2004) Heart failure prevalence, incidence, and mortality in the elderly with diabetes. Diabetes Care 27(3):699–703PubMedCrossRef

25.

Bisognano JD, Weinberger HD, Bohlmeyer TJ, Pende A, Raynolds MV, Sastravaha A, Roden R, Asano K, Blaxall BC, Wu SC, Communal C, Singh K, Colucci W, Bristow MR, Port DJ (2000) Myocardial-directed overexpression of the human beta(1)-adrenergic receptor in transgenic mice. J Mol Cell Cardiol 32(5):817–830PubMedCrossRef

26.

Bonora E, Targher G, Alberiche M, Formentini G, Calcaterra F, Lombardi S, Marini F, Poli M, Zenari L, Raffaelli A, Perbellini S, Zenere MB, Saggiani F, Bonadonna RC, Muggeo M (2002) Predictors of insulin sensitivity in type 2 diabetes mellitus. Diabet Med 19(7):535–542PubMedCrossRef

27.

Boudina S, Abel ED (2007) Diabetic cardiomyopathy revisited. Circulation 115(25):3213–3223PubMedCrossRef

28.

Bowling N, Walsh RA, Song G, Estridge T, Sandusky GE, Fouts RL, Mintze K, Pickard T, Roden R, Bristow MR, Sabbah HN, Mizrahi JL, Gromo G, King GL, Vlahos CJ (1999) Increased protein kinase c activity and expression of ca2+ -sensitive isoforms in the failing human heart. Circulation 99(3):384–391PubMed

29.

Braz JC, Gregory K, Pathak A, Zhao W, Sahin B, Klevitsky R, Kimball TF, Lorenz JN, Nairn AC, Liggett SB, Bodi I, Wang S, Schwartz A, Lakatta EG, DePaoli-Roach AA, Robbins J, Hewett TE, Bibb JA, Westfall MV, Kranias EG, Molkentin JD (2004) Pkc-alpha regulates cardiac contractility and propensity toward heart failure. Nat Med 10(3):248–254PubMedCrossRef

30.

Brown RA, Filipovich P, Walsh MF, Sowers JR (1996) Influence of sex, diabetes and ethanol on intrinsic contractile performance of isolated rat myocardium. Basic Res Cardiol 91(5):353–360PubMed

31.

Brunner F, Bras-Silva C, Cerdeira AS, Leite-Moreira AF (2006) Cardiovascular endothelins: essential regulators of cardiovascular homeostasis. Pharmacol Ther 111(2):508–531PubMedCrossRef

32.

Bucala R, Tracey KJ, Cerami A (1991) Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes. J Clin Invest 87(2):432–438PubMedCrossRef

33.

Cai L, Wang Y, Zhou G, Chen T, Song Y, Li X, Kang YJ (2006) Attenuation by metallothionein of early cardiac cell death via suppression of mitochondrial oxidative stress results in a prevention of diabetic cardiomyopathy. J Am Coll Cardiol 48(8):1688–1697PubMedCrossRef

34.

Campbell SE, Katwa LC (1997) Angiotensin ii stimulated expression of transforming growth factor-beta1 in cardiac fibroblasts and myofibroblasts. J Mol Cell Cardiol 29(7):1947–1958PubMedCrossRef

35.

Carr AA, Kowey PR, Devereux RB, Brenner BM, Dahlof B, Ibsen H, Lindholm LH, Lyle PA, Snapinn SM, Zhang Z, Edelman JM, Shahinfar S (2005) Hospitalizations for new heart failure among subjects with diabetes mellitus in the renaal and life studies. Am J Cardiol 96(11):1530–1536PubMedCrossRef

36.

Cerasola G, Donatelli M, Cottone S, D’Ignoto G, Grasso L, Morici ML, Terrizzi C, Verga S, Bompiani GD (1987) Effects of dynamic exercise and metabolic control on left ventricular performance in insulin-dependent diabetes mellitus. Acta Diabetol Lat 24(3):263–270PubMedCrossRef

37.

Cerutti F, Vigo A, Sacchetti C, Bessone A, Barattia G, Morello M, Casalucci D, Gastaldi L (1994) Evaluation of left ventricular diastolic function in insulin dependent diabetic children by m-mode and Doppler echocardiography. Panminerva Med 36(3):109–114PubMed

38.

Chatham JC, Seymour AM (2002) Cardiac carbohydrate metabolism in zucker diabetic fatty rats. Cardiovasc Res 55(1):104–112PubMedCrossRef

39.

Chen S, Evans T, Mukherjee K, Karmazyn M, Chakrabarti S (2000) Diabetes-induced myocardial structural changes: role of endothelin-1 and its receptors. J Mol Cell Cardiol 32(9):1621–1629PubMedCrossRef

40.

Chen S, Khan ZA, Cukiernik M, Chakrabarti S (2003) Differential activation of nf-kappa b and ap-1 in increased fibronectin synthesis in target organs of diabetic complications. Am J Physiol Endocrinol Metab 284(6):E1089–E1097PubMed

41.

Chou E, Suzuma I, Way KJ, Opland D, Clermont AC, Naruse K, Suzuma K, Bowling NL, Vlahos CJ, Aiello LP, King GL (2002) Decreased cardiac expression of vascular endothelial growth factor and its receptors in insulin-resistant and diabetic states: a possible explanation for impaired collateral formation in cardiac tissue. Circulation 105(3):373–379PubMedCrossRef

42.

Coats AJ, Anker SD (2000) Insulin resistance in chronic heart failure. J Cardiovasc Pharmacol 35(7 Suppl 4):S9–14

43.

Czech MP, Corvera S (1999) Signaling mechanisms that regulate glucose transport. J Biol Chem 274(4):1865–1868PubMedCrossRef

44.

De Angelis KL, Oliveira AR, Dall’Ago P, Peixoto LR, Gadonski G, Lacchini S, Fernandes TG, Irigoyen MC (2000) Effects of exercise training on autonomic and myocardial dysfunction in streptozotocin-diabetic rats. Braz J Med Biol Res 33(6):635–641PubMed

45.

De Groote P, Lamblin N, Mouquet F, Plichon D, McFadden E, Van Belle E, Bauters C (2004) Impact of diabetes mellitus on long-term survival in patients with congestive heart failure. Eur Heart J 25(8):656–662PubMedCrossRef

46.

DeBlieux PM, Barbee RW, McDonough KH, Shepherd RE (1993) Exercise training improves cardiac performance in diabetic rats. Proc Soc Exp Biol Med 203(2):209–213PubMed

47.

DeFronzo RA, Bonadonna RC, Ferrannini E (1992) Pathogenesis of niddm. A balanced overview. Diabetes Care 15(3):318–368

48.

Dent CL, Bowman AW, Scott MJ, Allen JS, Lisauskas JB, Janif M, Wickline SA, Kovacs SJ (2001) Echocardiographic characterization of fundamental mechanisms of abnormal diastolic filling in diabetic rats with a parameterized diastolic filling formalism. J Am Soc Echocardiogr 14(12):1166–1172PubMedCrossRef

49.

Devereux RB, Roman MJ, Paranicas M, O’Grady MJ, Lee ET, Welty TK, Fabsitz RR, Robbins D, Rhoades ER, Howard BV (2000) Impact of diabetes on cardiac structure and function: the strong heart study. Circulation 101(19):2271–2276PubMed

50.

Di Bello V, Talarico L, Picano E, Di Muro C, Landini L, Paterni M, Matteucci E, Giusti C, Giampietro O (1995) Increased echodensity of myocardial wall in the diabetic heart: an ultrasound tissue characterization study. J Am Coll Cardiol 25(6):1408–1415PubMedCrossRef

51.

Di Bonito P, Cuomo S, Moio N, Sibilio G, Sabatini D, Quattrin S, Capaldo B (1996) Diastolic dysfunction in patients with non-insulin-dependent diabetes mellitus of short duration. Diabet Med 13(4):321–324PubMedCrossRef

52.

Di Bonito P, Moio N, Cavuto L, Covino G, Murena E, Scilla C, Turco S, Capaldo B, Sibilio G (2005) Early detection of diabetic cardiomyopathy: usefulness of tissue Doppler imaging. Diabet Med 22(12):1720–1725PubMedCrossRef

53.

Di Carli MF, Bianco-Batlles D, Landa ME, Kazmers A, Groehn H, Muzik O, Grunberger G (1999) Effects of autonomic neuropathy on coronary blood flow in patients with diabetes mellitus. Circulation 100(8):813–819PubMed

54.

Dries DL, Sweitzer NK, Drazner MH, Stevenson LW, Gersh BJ (2001) Prognostic impact of diabetes mellitus in patients with heart failure according to the etiology of left ventricular systolic dysfunction. J Am Coll Cardiol 38(2):421–428PubMedCrossRef

55.

Du X, Matsumura T, Edelstein D, Rossetti L, Zsengeller Z, Szabo C, Brownlee M (2003) Inhibition of gapdh activity by poly(adp-ribose) polymerase activates three major pathways of hyperglycemic damage in endothelial cells. J Clin Invest 112(7):1049–1057PubMed

56.

Duckworth W, Abraira C, Moritz T, Reda D, Emanuele N, Reaven PD, Zieve FJ, Marks J, Davis SN, Hayward R, Warren SR, Goldman S, McCarren M, Vitek ME, Henderson WG, Huang GD (2009) Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med 360(2):129–139PubMedCrossRef

57.

Dutta K, Podolin DA, Davidson MB, Davidoff AJ (2001) Cardiomyocyte dysfunction in sucrose-fed rats is associated with insulin resistance. Diabetes 50(5):1186–1192PubMedCrossRef

58.

Eckel J, Reinauer H (1990) Insulin action on glucose transport in isolated cardiac myocytes: signalling pathways and diabetes-induced alterations. Biochem Soc Trans 18(6):1125–1127PubMed

59.

Erbas T, Erbas B, Kabakci G, Aksoyek S, Koray Z, Gedik O (2000) Plasma big-endothelin levels, cardiac autonomic neuropathy, and cardiac functions in patients with insulin-dependent diabetes mellitus. Clin Cardiol 23(4):259–263PubMedCrossRef

60.

Eurich DT, Majumdar SR, McAlister FA, Tsuyuki RT, Johnson JA (2005) Improved clinical outcomes associated with metformin in patients with diabetes and heart failure. Diabetes Care 28(10):2345–2351PubMedCrossRef

61.

Falcao-Pires I, Goncalves N, Moura C, Lamego I, Eloy C, Lopes JM, Begieneman MP, Niessen HW, Areias JC, Leite-Moreira AF (2009) Effects of diabetes mellitus, pressure-overload and their association on myocardial structure and function. Am J Hypertens 22(11):1190–1198PubMedCrossRef

62.

Fang ZY, Yuda S, Anderson V, Short L, Case C, Marwick TH (2003) Echocardiographic detection of early diabetic myocardial disease. J Am Coll Cardiol 41(4):611–617PubMedCrossRef

63.

Fiordaliso F, Leri A, Cesselli D, Limana F, Safai B, Nadal-Ginard B, Anversa P, Kajstura J (2001) Hyperglycemia activates p53 and p53-regulated genes leading to myocyte cell death. Diabetes 50(10):2363–2375PubMedCrossRef

64.

Fiordaliso F, Cuccovillo I, Bianchi R, Bai A, Doni M, Salio M, De Angelis N, Ghezzi P, Latini R, Masson S (2006) Cardiovascular oxidative stress is reduced by an ace inhibitor in a rat model of streptozotocin-induced diabetes. Life Sci 79(2):121–129PubMedCrossRef

65.

Fischer VW, Barner HB, Larose LS (1984) Pathomorphologic aspects of muscular tissue in diabetes mellitus. Hum Pathol 15(12):1127–1136PubMedCrossRef

66.

Florkowski CM (2002) Management of co-existing diabetes mellitus and dyslipidemia: defining the role of thiazolidinediones. Am J Cardiovasc Drugs 2(1):15–21PubMedCrossRef

67.

Friedman NE, Levitsky LL, Edidin DV, Vitullo DA, Lacina SJ, Chiemmongkoltip P (1982) Echocardiographic evidence for impaired myocardial performance in children with type i diabetes mellitus. Am J Med 73(6):846–850PubMedCrossRef

68.

Frustaci A, Kajstura J, Chimenti C, Jakoniuk I, Leri A, Maseri A, Nadal-Ginard B, Anversa P (2000) Myocardial cell death in human diabetes. Circ Res 87(12):1123–1132PubMed

69.

Galderisi M, Anderson KM, Wilson PW, Levy D (1991) Echocardiographic evidence for the existence of a distinct diabetic cardiomyopathy (the framingham heart study). Am J Cardiol 68(1):85–89PubMedCrossRef

70.

Galderisi M, Paolisso G, Tagliamonte MR, Alfieri A, Petrocelli A, de Divitiis M, Varricchio M, de Divitiis O (1997) Is insulin action a determinant of left ventricular relaxation in uncomplicated essential hypertension? J Hypertens 15(7):745–750PubMedCrossRef

71.

Galderisi M (2006) Diastolic dysfunction and diabetic cardiomyopathy: evaluation by doppler echocardiography. J Am Coll Cardiol 48(8):1548–1551PubMedCrossRef

72.

Ganguly PK, Pierce GN, Dhalla KS, Dhalla NS (1983) Defective sarcoplasmic reticular calcium transport in diabetic cardiomyopathy. Am J Physiol 244(6):E528–E535PubMed

73.

Ganguly PK, Thliveris JA, Mehta A (1990) Evidence against the involvement of nonenzymatic glycosylation in diabetic cardiomyopathy. Metabolism 39(7):769–773PubMedCrossRef

74.

Gao WD, Liu Y, Marban E (1996) Selective effects of oxygen free radicals on excitation-contraction coupling in ventricular muscle. Implications for the mechanism of stunned myocardium. Circulation 94(10):2597–2604

75.

Garay-Sevilla ME, Nava LE, Malacara JM, Wrobel K, Perez U (2000) Advanced glycosylation end products (ages), insulin-like growth factor-1 (igf-1) and igf-binding protein-3 (igfbp-3) in patients with type 2 diabetes mellitus. Diabetes Metab Res Rev 16(2):106–113PubMedCrossRef

76.

Gerschenson LE, Rotello RJ (1992) Apoptosis: a different type of cell death. FASEB J 6(7):2450–2455PubMed

77.

Gerstein HC, Miller ME, Byington RP, Goff DC Jr, Bigger JT, Buse JB, Cushman WC, Genuth S, Ismail-Beigi F, Grimm RH Jr, Probstfield JL, Simons-Morton DG, Friedewald WT (2008) Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 358(24):2545–2559PubMedCrossRef

78.

Giacomelli F, Wiener J (1979) Primary myocardial disease in the diabetic mouse. An ultrastructural study. Lab Invest 40(4):460–473

79.

Giampietro O, Di Bello V, Matteucci E, Talarico L, Ruberti F, Boldrini E, Giorgi D, Giusti C (1997) Erythrocyte na+/h+ exchange and preclinical abnormalities of the left ventricular diastolic function in normotensive type 1 (insulin-dependent) diabetic Patients. Acta Diabetol 34(3):223–229PubMedCrossRef

80.

Golfman L, Dixon IM, Takeda N, Lukas A, Dakshinamurti K, Dhalla NS (1998) Cardiac sarcolemmal na(+)-ca2+ exchange and na(+)-k+ atpase activities and gene expression in alloxan-induced diabetes in rats. Mol Cell Biochem 188(1–2):91–101PubMedCrossRef

81.

Gottdiener JS, Arnold AM, Aurigemma GP, Polak JF, Tracy RP, Kitzman DW, Gardin JM, Rutledge JE, Boineau RC (2000) Predictors of congestive heart failure in the elderly: the cardiovascular health study. J Am Coll Cardiol 35(6):1628–1637PubMedCrossRef

82.

Greer JJ, Ware DP, Lefer DJ (2006) Myocardial infarction and heart failure in the db/db diabetic mouse. Am J Physiol Heart Circ Physiol 290(1):H146–H153PubMedCrossRef

83.

Guan Y, Hao C, Cha DR, Rao R, Lu W, Kohan DE, Magnuson MA, Redha R, Zhang Y, Breyer MD (2005) Thiazolidinediones expand body fluid volume through ppargamma stimulation of enac-mediated renal salt absorption. Nat Med 11(8):861–866PubMedCrossRef

84.

Guida L, Celentano A, Iannuzzi R, Ferrara LA (2001) Insulin resistance, ventricular mass and function in normoglycaemic hypertensives. Nutr Metab Cardiovasc Dis 11(5):306–311PubMed

85.

Hall JL, Sexton WL, Stanley WC (1995) Exercise training attenuates the reduction in myocardial glut-4 in diabetic rats. J Appl Physiol 78(1):76–81PubMed

86.

Hambleton M, Hahn H, Pleger ST, Kuhn MC, Klevitsky R, Carr AN, Kimball TF, Hewett TE, Dorn GW 2nd, Koch WJ, Molkentin JD (2006) Pharmacological- and gene therapy-based inhibition of protein kinase calpha/beta enhances cardiac contractility and attenuates heart failure. Circulation 114(6):574–582PubMedCrossRef

87.

Hattori Y, Matsuda N, Kimura J, Ishitani T, Tamada A, Gando S, Kemmotsu O, Kanno M (2000) Diminished function and expression of the cardiac na+ -ca2+ exchanger in diabetic rats: implication in ca2+ overload. J Physiol 527(Pt 1):85–94

88.

Haunstetter A, Izumo S (1998) Apoptosis: basic mechanisms and implications for cardiovascular disease. Circ Res 82(11):1111–1129PubMed

89.

Hayashi K, Okumura K, Matsui H, Murase K, Kamiya H, Saburi Y, Numaguchi Y, Toki Y, Hayakawa T (2001) Involvement of 1, 2-diacylglycerol in improvement of heart function by etomoxir in diabetic rats. Life Sci 68(13):1515–1526PubMedCrossRef

90.

Held C, Gerstein HC, Yusuf S, Zhao F, Hilbrich L, Anderson C, Sleight P, Teo K (2007) Glucose levels predict hospitalization for congestive heart failure in patients at high cardiovascular risk. Circulation 115(11):1371–1375PubMedCrossRef

91.

Henriksen EJ, Jacob S, Kinnick TR, Youngblood EB, Schmit MB, Dietze GJ (1999) Ace inhibition and glucose transport in insulinresistant muscle: roles of bradykinin and nitric oxide. Am J Physiol 277(1 Pt 2):R332–336

92.

Hintz KK, Ren J (2002) Prediabetic insulin resistance is not permissive to the development of cardiac resistance to insulin-like growth factor i in ventricular myocytes. Diabetes Res Clin Pract 55(2):89–98PubMedCrossRef

93.

Hoit BD, Castro C, Bultron G, Knight S, Matlib MA (1999) Noninvasive evaluation of cardiac dysfunction by echocardiography in streptozotocin-induced diabetic rats. J Card Fail 5(4):324–333PubMedCrossRef

94.

Hornig B, Arakawa N, Kohler C, Drexler H (1998) Vitamin c improves endothelial function of conduit arteries in patients with chronic heart failure. Circulation 97(4):363–368PubMed

95.

Hoshida S, Yamashita N, Otsu K, Kuzuya T, Hori M (2000) Cholesterol feeding exacerbates myocardial injury in zucker diabetic fatty rats. Am J Physiol Heart Circ Physiol 278(1):H256–H262PubMed

96.

Ilercil A, Devereux RB, Roman MJ, Paranicas M, O’Grady MJ, Welty TK, Robbins DC, Fabsitz RR, Howard BV, Lee ET (2001) Relationship of impaired glucose tolerance to left ventricular structure and function: the strong heart study. Am Heart J 141(6):992–998PubMedCrossRef

97.

Iribarren C, Karter AJ, Go AS, Ferrara A, Liu JY, Sidney S, Selby JV (2001) Glycemic control and heart failure among adult patients with diabetes. Circulation 103(22):2668–2673PubMed

98.

Jermendy G, Koltai MZ, Kammerer L, Cserhalmi L, Istvanffy M, Szelenyi J, Pogatsa G (1984) Myocardial systolic alterations of insulin-dependent diabetics in rest. Acta Cardiol 39(3):185–190PubMed

99.

Joffe II, Travers KE, Perreault-Micale CL, Hampton T, Katz SE, Morgan JP, Douglas PS (1999) Abnormal cardiac function in the streptozotocin-induced non-insulin-dependent diabetic rat: noninvasive assessment with Doppler echocardiography and contribution of the nitric oxide pathway. J Am Coll Cardiol 34(7):2111–2119PubMedCrossRef

100.

Johnstone MT, Creager SJ, Scales KM, Cusco JA, Lee BK, Creager MA (1993) Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus. Circulation 88(6):2510–2516PubMed

101.

Kahn JK, Zola B, Juni JE, Vinik AI (1986) Radionuclide assessment of left ventricular diastolic filling in diabetes mellitus with and without cardiac autonomic neuropathy. J Am Coll Cardiol 7(6):1303–1309PubMedCrossRef

102.

Kannel WB, Hjortland M, Castelli WP (1974) Role of diabetes in congestive heart failure: the framingham study. Am J Cardiol 34(1):29–34PubMedCrossRef

103.

Kawasaki D, Kosugi K, Waki H, Yamamoto K, Tsujino T, Masuyama T (2007) Role of activated renin-angiotensin system in myocardial fibrosis and left ventricular diastolic dysfunction in diabetic patients–reversal by chronic angiotensin ii type 1a receptor blockade. Circ J 71(4):524–529PubMedCrossRef

104.

Kim HW, Ch YS, Lee HR, Park SY, Kim YH (2001) Diabetic alterations in cardiac sarcoplasmic reticulum ca2+ -atpase and phospholamban protein expression. Life Sci 70(4):367–379PubMedCrossRef

105.

King H, Aubert RE, Herman WH (1998) Global burden of diabetes, 1995–2025: Prevalence, numerical estimates, and projections. Diabetes Care 21(9):1414–1431PubMedCrossRef

106.

Kohn AD, Summers SA, Birnbaum MJ, Roth RA (1996) Expression of a constitutively active akt ser/thr kinase in 3t3–l1 adipocytes stimulates glucose uptake and glucose transporter 4 translocation. J Biol Chem 271(49):31372–31378PubMedCrossRef

107.

Koya D, King GL (1998) Protein kinase c activation and the development of diabetic complications. Diabetes 47(6):859–866PubMedCrossRef

108.

Lam CS, Roger VL, Rodeheffer RJ, Bursi F, Borlaug BA, Ommen SR, Kass DA, Redfield MM (2007) Cardiac structure and ventricular-vascular function in persons with heart failure and preserved ejection fraction from olmsted county, minnesota. Circulation 115(15):1982–1990PubMedCrossRef

109.

Lee AA, Dillmann WH, McCulloch AD, Villarreal FJ (1995) Angiotensin ii stimulates the autocrine production of transforming growth factor-beta 1 in adult rat cardiac fibroblasts. J Mol Cell Cardiol 27(10):2347–2357PubMedCrossRef

110.

Lee M, Gardin JM, Lynch JC, Smith VE, Tracy RP, Savage PJ, Szklo M, Ward BJ (1997) Diabetes mellitus and echocardiographic left ventricular function in free-living elderly men and women: the cardiovascular health study. Am Heart J 133(1):36–43PubMedCrossRef

111.

Lee SH, Wolf PL, Escudero R, Deutsch R, Jamieson SW, Thistlethwaite PA (2000) Early expression of angiogenesis factors in acute myocardial ischemia and infarction. N Engl J Med 342(9):626–633PubMedCrossRef

112.

Levine B, Kalman J, Mayer L, Fillit HM, Packer M (1990) Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med 323(4):236–241PubMedCrossRef

113.

Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP (1990) Prognostic implications of echocardiographically determined left ventricular mass in the framingham heart study. N Engl J Med 322(22):1561–1566PubMedCrossRef

114.

Li B, Setoguchi M, Wang X, Andreoli AM, Leri A, Malhotra A, Kajstura J, Anversa P (1999) Insulin-like growth factor-1 attenuates the detrimental impact of nonocclusive coronary artery constriction on the heart. Circ Res 84(9):1007–1019PubMed

115.

Li JM, Gall NP, Grieve DJ, Chen M, Shah AM (2002) Activation of nadph oxidase during progression of cardiac hypertrophy to failure. Hypertension 40(4):477–484PubMedCrossRef

116.

Liang Q, Carlson EC, Donthi RV, Kralik PM, Shen X, Epstein PN (2002) Overexpression of metallothionein reduces diabetic cardiomyopathy. Diabetes 51(1):174–181PubMedCrossRef

117.

Liedtke AJ, DeMaison L, Eggleston AM, Cohen LM, Nellis SH (1988) Changes in substrate metabolism and effects of excess fatty acids in reperfused myocardium. Circ Res 62(3):535–542PubMed

118.

Lind L, Berne C, Andren B, Lithell H (1996) Relationship between diastolic hypertension and myocardial morphology and function in elderly males with diabetes mellitus. Diabetologia 39(12):1603–1606PubMedCrossRef

119.

Litwin SE, Raya TE, Anderson PG, Daugherty S, Goldman S (1990) Abnormal cardiac function in the streptozotocin-diabetic rat. Changes in active and passive properties of the left ventricle. J Clin Invest 86(2):481–488

120.

Liu JE, Palmieri V, Roman MJ, Bella JN, Fabsitz R, Howard BV, Welty TK, Lee ET, Devereux RB (2001) The impact of diabetes on left ventricular filling pattern in normotensive and hypertensive adults: the strong heart study. J Am Coll Cardiol 37(7):1943–1949PubMedCrossRef

121.

Liu X, Suzuki H, Sethi R, Tappia PS, Takeda N, Dhalla NS (2006) Blockade of the renin-angiotensin system attenuates sarcolemma and sarcoplasmic reticulum remodeling in chronic diabetes. Ann N Y Acad Sci 1084:141–154

122.

Liu Y, Cox SR, Morita T, Kourembanas S (1995) Hypoxia regulates vascular endothelial growth factor gene expression in endothelial cells. Identification of a 5’ enhancer. Circ Res 77(3):638–643

123.

Lowes BD, Gill EA, Abraham WT, Larrain JR, Robertson AD, Bristow MR, Gilbert EM (1999) Effects of carvedilol on left ventricular mass, chamber geometry, and mitral regurgitation in chronic heart failure. Am J Cardiol 83(8):1201–1205PubMedCrossRef

124.

MacCarthy PA, Grieve DJ, Li JM, Dunster C, Kelly FJ, Shah AM (2001) Impaired endothelial regulation of ventricular relaxation in cardiac hypertrophy: role of reactive oxygen species and nadph oxidase. Circulation 104(24):2967–2974PubMedCrossRef

125.

Malhotra A, Reich D, Nakouzi A, Sanghi V, Geenen DL, Buttrick PM (1997) Experimental diabetes is associated with functional activation of protein kinase c epsilon and phosphorylation of troponin i in the heart, which are prevented by angiotensin ii receptor blockade. Circ Res 81(6):1027–1033PubMed

126.

Mantysaari M, Kuikka J, Mustonen J, Tahvanainen K, Vanninen E, Lansimies E, Uusitupa M (1992) Noninvasive detection of cardiac sympathetic nervous dysfunction in diabetic patients using [123i]metaiodobenzylguanidine. Diabetes 41(9):1069–1075PubMedCrossRef

127.

Marfella R, Di Filippo C, Esposito K, Nappo F, Piegari E, Cuzzocrea S, Berrino L, Rossi F, Giugliano D, D’Amico M (2004) Absence of inducible nitric oxide synthase reduces myocardial damage during ischemia reperfusion in streptozotocin-induced hyperglycemic mice. Diabetes 53(2):454–462PubMedCrossRef

128.

Masoudi FA, Wang Y, Inzucchi SE, Setaro JF, Havranek EP, Foody JM, Krumholz HM (2003) Metformin and thiazolidinedione use in medicare patients with heart failure. JAMA 290(1):81–85PubMedCrossRef

129.

Matteucci E, Di Bello V, Giampietro O (1995) Integrated analysis of erythrocyte na+/h+ antiport activity and left ventricular myocardial function in type i insulin-dependent diabetes mellitus. J Diabetes Complications 9(4):208–211PubMedCrossRef

130.

Mbanya JC, Sobngwi E, Mbanya DS, Ngu KB (2001) Left ventricular mass and systolic function in African diabetic patients: association with microalbuminuria. Diabetes Metab 27(3):378–382PubMed

131.

McEwan PE, Gray GA, Sherry L, Webb DJ, Kenyon CJ (1998) Differential effects of angiotensin ii on cardiac cell proliferation and intramyocardial perivascular fibrosis in vivo. Circulation 98(24):2765–2773PubMed

132.

Mildenberger RR, Bar-Shlomo B, Druck MN, Jablonsky G, Morch JE, Hilton JD, Kenshole AB, Forbath N, McLaughlin PR (1984) Clinically unrecognized ventricular dysfunction in young diabetic patients. J Am Coll Cardiol 4(2):234–238PubMedCrossRef

133.

Miles PD, Romeo OM, Higo K, Cohen A, Rafaat K, Olefsky JM (1997) Tnf-alpha-induced insulin resistance in vivo and its prevention by troglitazone. Diabetes 46(11):1678–1683PubMedCrossRef

134.

Minchenko AG, Stevens MJ, White L, Abatan OI, Komjati K, Pacher P, Szabo C, Obrosova IG (2003) Diabetes-induced overexpression of endothelin-1 and endothelin receptors in the rat renal cortex is mediated via poly(adp-ribose) polymerase activation. FASEB J 17(11):1514–1516PubMed

135.

Mizushige K, Yao L, Noma T, Kiyomoto H, Yu Y, Hosomi N, Ohmori K, Matsuo H (2000) Alteration in left ventricular diastolic filling and accumulation of myocardial collagen at insulin-resistant prediabetic stage of a type ii diabetic rat model. Circulation 101(8):899–907PubMed

136.

Monteagudo PT, Moises VA, Kohlmann O Jr, Ribeiro AB, Lima VC, Zanella MT (2000) Influence of autonomic neuropathy upon left ventricular dysfunction in insulin-dependent diabetic patients. Clin Cardiol 23(5):371–375PubMedCrossRef

137.

Moye LA, Pfeffer MA, Wun CC, Davis BR, Geltman E, Hayes D, Farnham DJ, Randall OS, Dinh H, Arnold JM, et al. (1994) Uniformity of captopril benefit in the save study: subgroup analysis. Survival and ventricular enlargement study. Eur Heart J 15(Suppl B:2–8; (discussion 26–30)

138.

Mustonen J, Mantysaari M, Kuikka J, Vanninen E, Vainio P, Lansimies E, Uusitupa M (1992) Decreased myocardial 123i-metaiodobenzylguanidine uptake is associated with disturbed left ventricular diastolic filling in diabetes. Am Heart J 123(3):804–805PubMedCrossRef

139.

Mustonen JN, Uusitupa MI, Laakso M, Vanninen E, Lansimies E, Kuikka JT, Pyorala K (1994) Left ventricular systolic function in middle-aged patients with diabetes mellitus. Am J Cardiol 73(16):1202–1208PubMedCrossRef

140.

Nakayama H, Morozumi T, Nanto S, Shimonagata T, Ohara T, Takano Y, Kotani J, Watanabe T, Fujita M, Nishio M, Kusuoka H, Hori M, Nagata S (2001) Abnormal myocardial free fatty acid utilization deteriorates with morphological changes in the hypertensive heart. Jpn Circ J 65(9):783–787PubMedCrossRef

141.

Neubauer B, Christensen NJ (1976) Norepinephrine, epinephrine, and dopamine contents of the cardiovascular system in long-term diabetics. Diabetes 25(1):6–10PubMedCrossRef

142.

Neumann S, Huse K, Semrau R, Diegeler A, Gebhardt R, Buniatian GH, Scholz GH (2002) Aldosterone and d-glucose stimulate the proliferation of human cardiac myofibroblasts in vitro. Hypertension 39(3):756–760PubMedCrossRef

143.

Nichols GA, Hillier TA, Erbey JR, Brown JB (2001) Congestive heart failure in type 2 diabetes: prevalence, incidence, and risk factors. Diabetes Care 24(9):1614–1619PubMedCrossRef

144.

Nichols GA, Gullion CM, Koro CE, Ephross SA, Brown JB (2004) The incidence of congestive heart failure in type 2 diabetes: an update. Diabetes Care 27(8):1879–1884PubMedCrossRef

145.

Nicolino A, Longobardi G, Furgi G, Rossi M, Zoccolillo N, Ferrara N, Rengo F (1995) Left ventricular diastolic filling in diabetes mellitus with and without hypertension. Am J Hypertens 8(4 Pt 1):382–389

146.

Nitenberg A, Valensi P, Sachs R, Dali M, Aptecar E, Attali JR (1993) Impairment of coronary vascular reserve and ach-induced coronary vasodilation in diabetic patients with angiographically normal coronary arteries and normal left ventricular systolic function. Diabetes 42(7):1017–1025PubMedCrossRef

147.

Nunoda S, Genda A, Sugihara N, Nakayama A, Mizuno S, Takeda R (1985) Quantitative approach to the histopathology of the biopsied right ventricular myocardium in patients with diabetes mellitus. Heart Vessels 1(1):43–47PubMedCrossRef

148.

Orea-Tejeda A, Colin-Ramirez E, Castillo-Martinez L, Asensio-Lafuente E, Corzo-Leon D, Gonzalez-Toledo R, Rebollar-Gonzalez V, Narvaez-David R, Dorantes-Garcia J (2007) Aldosterone receptor antagonists induce favorable cardiac remodeling in diastolic heart failure patients. Rev Invest Clin 59(2):103–107PubMed

149.

Osborn BA, Daar JT, Laddaga RA, Romano FD, Paulson DJ (1997) Exercise training increases sarcolemmal glut-4 protein and mrna content in diabetic heart. J Appl Physiol 82(3):828–834PubMed

150.

Pacher P, Liaudet L, Soriano FG, Mabley JG, Szabo E, Szabo C (2002) The role of poly(adp-ribose) polymerase activation in the development of myocardial and endothelial dysfunction in diabetes. Diabetes 51(2):514–521PubMedCrossRef

151.

Paillole C, Dahan M, Paycha F, Solal AC, Passa P, Gourgon R (1989) Prevalence and significance of left ventricular filling abnormalities determined by doppler echocardiography in young type i (insulin-dependent) diabetic patients. Am J Cardiol 64(16):1010–1016PubMedCrossRef

152.

Palmieri V, Bella JN, Arnett DK, Liu JE, Oberman A, Schuck MY, Kitzman DW, Hopkins PN, Morgan D, Rao DC, Devereux RB (2001) Effect of type 2 diabetes mellitus on left ventricular geometry and systolic function in hypertensive subjects: hypertension genetic epidemiology network (hypergen) study. Circulation 103(1):102–107PubMed

153.

Park JW, Ziegler AG, Janka HU, Doering W, Mehnert H (1988) Left ventricular relaxation and filling pattern in diabetic heart muscle disease: an echocardiographic study. Klin Wochenschr 66(17):773–778PubMedCrossRef

154.

Patel A, MacMahon S, Chalmers J, Neal B, Billot L, Woodward M, Marre M, Cooper M, Glasziou P, Grobbee D, Hamet P, Harrap S, Heller S, Liu L, Mancia G, Mogensen CE, Pan C, Poulter N, Rodgers A, Williams B, Bompoint S, de Galan BE, Joshi R, Travert F (2008) Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 358(24):2560–2572PubMedCrossRef

155.

Paulson DJ (1997) The diabetic heart is more sensitive to ischemic injury. Cardiovasc Res 34(1):104–112PubMedCrossRef

156.

Paulus WJ, Tschope C, Sanderson JE, Rusconi C, Flachskampf FA, Rademakers FE, Marino P, Smiseth OA, De Keulenaer G, Leite-Moreira AF, Borbely A, Edes I, Handoko ML, Heymans S, Pezzali N, Pieske B, Dickstein K, Fraser AG, Brutsaert DL (2007) How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the heart failure and echocardiography associations of the european society of cardiology. Eur Heart J 28(20):2539–2550PubMedCrossRef

157.

Pessin JE, Saltiel AR (2000) Signaling pathways in insulin action: molecular targets of insulin resistance. J Clin Invest 106(2):165–169PubMedCrossRef

158.

Petrie MC, Caruana L, Berry C, McMurray JJ (2002) “Diastolic heart failure” Or heart failure caused by subtle left ventricular systolic dysfunction? Heart 87(1):29–31PubMedCrossRef

159.

Pogatsa G, Bihari-Varga M, Szinay G (1979) Effect of diabetes therapy on the myocardium in experimental diabetes. Acta Diabetol Lat 16(2):129–138PubMedCrossRef

160.

Poirier P, Bogaty P, Garneau C, Marois L, Dumesnil JG (2001) Diastolic dysfunction in normotensive men with well-controlled type 2 diabetes: importance of maneuvers in echocardiographic screening for preclinical diabetic cardiomyopathy. Diabetes Care 24(1):5–10PubMedCrossRef

161.

Privratsky JR, Wold LE, Sowers JR, Quinn MT, Ren J (2003) At1 blockade prevents glucose-induced cardiac dysfunction in ventricular myocytes: role of the at1 receptor and nadph oxidase. Hypertension 42(2):206–212PubMedCrossRef

162.

Raev DC (1994) Left ventricular function and specific diabetic complications in other target organs in young insulin-dependent diabetics: an echocardiographic study. Heart Vessels 9(3):121–128PubMedCrossRef

163.

Raev DC (1994) Which left ventricular function is impaired earlier in the evolution of diabetic cardiomyopathy? An echocardiographic study of young type i diabetic patients. Diabetes Care 17(7):633–639PubMedCrossRef

164.

Raimondi L, De Paoli P, Mannucci E, Lonardo G, Sartiani L, Banchelli G, Pirisino R, Mugelli A, Cerbai E (2004) Restoration of cardiomyocyte functional properties by angiotensin ii receptor blockade in diabetic rats. Diabetes 53(7):1927–1933PubMedCrossRef

165.

Rajan SK, Gokhale SM (2002) Cardiovascular function in patients with insulin-dependent diabetes mellitus: a study using noninvasive methods. Ann N Y Acad Sci 958:425–430

166.

Regan TJ, Wu CF, Yeh CK, Oldewurtel HA, Haider B (1981) Myocardial composition and function in diabetes. The effects of chronic insulin use. Circ Res 49(6):1268–1277

167.

Ritchie RH, Quinn JM, Cao AH, Drummond GR, Kaye DM, Favaloro JM, Proietto J, Delbridge LM (2007) The antioxidant tempol inhibits cardiac hypertrophy in the insulin-resistant glut4-deficient mouse in vivo. J Mol Cell Cardiol 42(6):1119–1128PubMedCrossRef

168.

Rodrigues B, Cam MC, McNeill JH (1995) Myocardial substrate metabolism: implications for diabetic cardiomyopathy. J Mol Cell Cardiol 27(1):169–179PubMedCrossRef

169.

Rodrigues B, Cam MC, McNeill JH (1998) Metabolic disturbances in diabetic cardiomyopathy. Mol Cell Biochem 180(1–2):53–57PubMedCrossRef

170.

Rosen R, Rump AF, Rosen P (1995) The ace-inhibitor captopril improves myocardial perfusion in spontaneously diabetic (bb) rats. Diabetologia 38(5):509–517PubMedCrossRef

171.

Rubler S, Dlugash J, Yuceoglu YZ, Kumral T, Branwood AW, Grishman A (1972) New type of cardiomyopathy associated with diabetic glomerulosclerosis. Am J Cardiol 30(6):595–602PubMedCrossRef

172.

Rutter MK, Parise H, Benjamin EJ, Levy D, Larson MG, Meigs JB, Nesto RW, Wilson PW, Vasan RS (2003) Impact of glucose intolerance and insulin resistance on cardiac structure and function: sex-related differences in the framingham heart study. Circulation 107(3):448–454PubMedCrossRef

173.

Saito F, Kawaguchi M, Izumida J, Asakura T, Maehara K, Maruyama Y (2003) Alteration in haemodynamics and pathological changes in the cardiovascular system during the development of type 2 diabetes mellitus in oletf rats. Diabetologia 46(8):1161–1169PubMedCrossRef

174.

Schaible TF, Malhotra A, Bauman WA, Scheuer J (1983) Left ventricular function after chronic insulin treatment in diabetic and normal rats. J Mol Cell Cardiol 15(7):445–458PubMedCrossRef

175.

Schannwell CM, Schneppenheim M, Perings S, Plehn G, Strauer BE (2002) Left ventricular diastolic dysfunction as an early manifestation of diabetic cardiomyopathy. Cardiology 98(1–2):33–39PubMedCrossRef

176.

Schmitz-Peiffer C (2000) Signalling aspects of insulin resistance in skeletal muscle: mechanisms induced by lipid oversupply. Cell Signal 12(9–10):583–594PubMedCrossRef

177.

Schnell O, Muhr D, Weiss M, Dresel S, Haslbeck M, Standl E (1996) Reduced myocardial 123i-metaiodobenzylguanidine uptake in newly diagnosed iddm patients. Diabetes 45(6):801–805PubMedCrossRef

178.

Scognamiglio R, Avogaro A, Casara D, Crepaldi C, Marin M, Palisi M, Mingardi R, Erle G, Fasoli G, Dalla Volta S (1998) Myocardial dysfunction and adrenergic cardiac innervation in patients with insulin-dependent diabetes mellitus. J Am Coll Cardiol 31(2):404–412PubMedCrossRef

179.

Sebbag L, Forrat R, Canet E, Wiernsperger N, Delaye J, Renaud S, De Lorgeril M (1994) Effect of experimental non-insulin requiring diabetes on myocardial microcirculation during ischaemia in dogs. Eur J Clin Invest 24(10):686–690PubMedCrossRef

180.

Seddon M, Looi YH, Shah AM (2007) Oxidative stress and redox signalling in cardiac hypertrophy and heart failure. Heart 93(8):903–907PubMedCrossRef

181.

Semeniuk LM, Kryski AJ, Severson DL (2002) Echocardiographic assessment of cardiac function in diabetic db/db and transgenic db/db-hglut4 mice. Am J Physiol Heart Circ Physiol 283(3):H976–H982PubMed

182.

Shekelle PG, Rich MW, Morton SC, Atkinson CS, Tu W, Maglione M, Rhodes S, Barrett M, Fonarow GC, Greenberg B, Heidenreich PA, Knabel T, Konstam MA, Steimle A, Warner Stevenson L (2003) Efficacy of angiotensin-converting enzyme inhibitors and beta-blockers in the management of left ventricular systolic dysfunction according to race, gender, and diabetic status: a meta-analysis of major clinical trials. J Am Coll Cardiol 41(9):1529–1538PubMedCrossRef

183.

Shimizu M, Umeda K, Sugihara N, Yoshio H, Ino H, Takeda R, Okada Y, Nakanishi I (1993) Collagen remodelling in myocardia of patients with diabetes. J Clin Pathol 46(1):32–36PubMedCrossRef

184.

Shindler DM, Kostis JB, Yusuf S, Quinones MA, Pitt B, Stewart D, Pinkett T, Ghali JK, Wilson AC (1996) Diabetes mellitus, a predictor of morbidity and mortality in the studies of left ventricular dysfunction (solvd) trials and registry. Am J Cardiol 77(11):1017–1020PubMedCrossRef

185.

Shinohara K, Shinohara T, Mochizuki N, Mochizuki Y, Sawa H, Kohya T, Fujita M, Fujioka Y, Kitabatake A, Nagashima K (1996) Expression of vascular endothelial growth factor in human myocardial infarction. Heart Vessels 11(3):113–122PubMedCrossRef

186.

Shiomi T, Tsutsui H, Ikeuchi M, Matsusaka H, Hayashidani S, Suematsu N, Wen J, Kubota T, Takeshita A (2003) Streptozotocin-induced hyperglycemia exacerbates left ventricular remodeling and failure after experimental myocardial infarction. J Am Coll Cardiol 42(1):165–172PubMedCrossRef

187.

Shishehbor MH, Hoogwerf BJ, Schoenhagen P, Marso SP, Sun JP, Li J, Klein AL, Thomas JD, Garcia MJ (2003) Relation of hemoglobin a1c to left ventricular relaxation in patients with type 1 diabetes mellitus and without overt heart disease. Am J Cardiol 91(12):1514–1517, A1519

188.

Sowers JR, Epstein M, Frohlich ED (2001) Diabetes, hypertension, and cardiovascular disease: an update. Hypertension 37(4):1053–1059PubMed

189.

Stone PH, Muller JE, Hartwell T, York BJ, Rutherford JD, Parker CB, Turi ZG, Strauss HW, Willerson JT, Robertson T et al. (1989) The effect of diabetes mellitus on prognosis and serial left ventricular function after acute myocardial infarction: contribution of both coronary disease and diastolic left ventricular dysfunction to the adverse prognosis. The milis study group. J Am Coll Cardiol 14(1):49–57

190.

Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA, Hadden D, Turner RC, Holman RR (2000) Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (ukpds 35): Prospective observational study. BMJ 321(7258):405–412PubMedCrossRef

191.

Strauer BE, Motz W, Vogt M, Schwartzkopff B (1997) Impaired coronary flow reserve in niddm: a possible role for diabetic cardiopathy in humans. Diabetes 46(Suppl 2):S119–124

192.

Stroedter D, Schmidt T, Bretzel RG, Federlin K (1995) Glucose metabolism and left ventricular dysfunction are normalized by insulin and islet transplantation in mild diabetes in the rat. Acta Diabetol 32(4):235–243PubMedCrossRef

193.

Sun D, Nguyen N, DeGrado TR, Schwaiger M, Brosius FC 3rd (1994) Ischemia induces translocation of the insulin-responsive glucose transporter glut4 to the plasma membrane of cardiac myocytes. Circulation 89(2):793–798PubMed

194.

Swan JW, Anker SD, Walton C, Godsland IF, Clark AL, Leyva F, Stevenson JC, Coats AJ (1997) Insulin resistance in chronic heart failure: relation to severity and etiology of heart failure. J Am Coll Cardiol 30(2):527–532PubMedCrossRef

195.

Sykes CA, Wright AD, Malins JM, Pentecost BL (1977) Changes in systolic time intervals during treatment of diabetes mellitus. Br Heart J 39(3):255–259PubMedCrossRef

196.

Szabo C (2002) Parp as a drug target for the therapy of diabetic cardiovascular dysfunction. Drug News Perspect 15(4):197–205PubMedCrossRef

197.

Takeda N, Nakamura I, Hatanaka T, Ohkubo T, Nagano M (1988) Myocardial mechanical and myosin isoenzyme alterations in streptozotocin-diabetic rats. Jpn Heart J 29(4):455–463PubMedCrossRef

198.

Tang WH, Parameswaran AC, Maroo AP, Francis GS (2005) Aldosterone receptor antagonists in the medical management of chronic heart failure. Mayo Clin Proc 80(12):1623–1630PubMedCrossRef

199.

Tang WH (2007) Glycemic control and treatment patterns in patients with heart failure. Curr Cardiol Rep 9(3):242–247PubMedCrossRef

200.

Thakker GD, Frangogiannis NG, Bujak M, Zymek P, Gaubatz JW, Reddy AK, Taffet G, Michael LH, Entman ML, Ballantyne CM (2006) Effects of diet-induced obesity on inflammation and remodeling after myocardial infarction. Am J Physiol Heart Circ Physiol 291(5):H2504–H2514PubMedCrossRef

201.

Thompson EW (1994) Quantitative analysis of myocardial structure in insulin-dependent diabetes mellitus: effects of immediate and delayed insulin replacement. Proc Soc Exp Biol Med 205(4):294–305PubMed

202.

Thrainsdottir I, Malmberg K, Olsson A, Gutniak M, Ryden L (2004) Initial experience with glp-1 treatment on metabolic control and myocardial function in patients with type 2 diabetes mellitus and heart failure. Diab Vasc Dis Res 1(1):40–43PubMedCrossRef

203.

Tribouilloy C, Rusinaru D, Mahjoub H, Tartiere JM, Kesri-Tartiere L, Godard S, Peltier M (2008) Prognostic impact of diabetes mellitus in patients with heart failure and preserved ejection fraction: a prospective five-year study. Heart 94(11):1450–1455PubMedCrossRef

204.

Trost SU, Belke DD, Bluhm WF, Meyer M, Swanson E, Dillmann WH (2002) Overexpression of the sarcoplasmic reticulum ca(2+)-atpase improves myocardial contractility in diabetic cardiomyopathy. Diabetes 51(4):1166–1171PubMedCrossRef

205.

Turan B (2010) Role of antioxidants in redox regulation of diabetic cardiovascular complications. Curr Pharm Biotechnol 11(8):819–836PubMedCrossRef

206.

Turpeinen AK, Vanninen E, Kuikka JT, Uusitupa MI (1996) Demonstration of regional sympathetic denervation of the heart in diabetes. Comparison between patients with niddm and iddm. Diabetes Care 19(10):1083–1090

207.

Uekita K, Tobise K, Onodera S (1997) Enhancement of the cardiac beta-adrenergic system at an early diabetic state in spontaneously diabetic Chinese hamsters. Jpn Circ J 61(1):64–73PubMedCrossRef

208.

Uusitupa MI (1990) Fibre in the management of diabetes. BMJ 301(6743):122PubMedCrossRef

209.

van Heerebeek L, Hamdani N, Handoko ML, Falcao-Pires I, Musters RJ, Kupreishvili K, Ijsselmuiden AJ, Schalkwijk CG, Bronzwaer JG, Diamant M, Borbely A, van der Velden J, Stienen GJ, Laarman GJ, Niessen HW, Paulus WJ (2008) Diastolic stiffness of the failing diabetic heart: importance of fibrosis, advanced glycation end products, and myocyte resting tension. Circulation 117(1):43–51PubMedCrossRef

210.

Vered A, Battler A, Segal P, Liberman D, Yerushalmi Y, Berezin M, Neufeld HN (1984) Exercise-induced left ventricular dysfunction in young men with asymptomatic diabetes mellitus (diabetic cardiomyopathy). Am J Cardiol 54(6):633–637PubMedCrossRef

211.

Vetter R, Rehfeld U, Reissfelder C, Weiss W, Wagner KD, Gunther J, Hammes A, Tschope C, Dillmann W, Paul M (2002) Transgenic overexpression of the sarcoplasmic reticulum ca2+ atpase improves reticular ca2+ handling in normal and diabetic rat hearts. FASEB J 16(12):1657–1659PubMed

212.

von Bibra H, Hansen A, Dounis V, Bystedt T, Malmberg K, Ryden L (2004) Augmented metabolic control improves myocardial diastolic function and perfusion in patients with non-insulin dependent diabetes. Heart 90(12):1483–1484CrossRef

213.

von Bibra H, Siegmund T, Hansen A, Jensen J, Schumm-Draeger PM (2007) augmentation of myocardial function by improved glycemic control in patients with type 2 diabetes mellitus. Dtsch Med Wochenschr 132(14):729–734CrossRef

214.

Vuorinen-Markkola H, Yki-Jarvinen H (1995) Antihypertensive therapy with enalapril improves glucose storage and insulin sensitivity in hypertensive patients with non-insulin-dependent diabetes mellitus. Metabolism 44(1):85–89PubMedCrossRef

215.

Wakasaki H, Koya D, Schoen FJ, Jirousek MR, Ways DK, Hoit BD, Walsh RA, King GL (1997) Targeted overexpression of protein kinase c beta2 isoform in myocardium causes cardiomyopathy. Proc Natl Acad Sci U S A 94(17):9320–9325PubMedCrossRef

216.

Wang P, Chatham JC (2004) Onset of diabetes in zucker diabetic fatty (zdf) rats leads to improved recovery of function after ischemia in the isolated perfused heart. Am J Physiol Endocrinol Metab 286(5):E725–E736PubMedCrossRef

217.

Way KJ, Isshiki K, Suzuma K, Yokota T, Zvagelsky D, Schoen FJ, Sandusky GE, Pechous PA, Vlahos CJ, Wakasaki H, King GL (2002) Expression of connective tissue growth factor is increased in injured myocardium associated with protein kinase c beta2 activation and diabetes. Diabetes 51(9):2709–2718PubMedCrossRef

218.

Weber KT, Brilla CG (1991) Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system. Circulation 83(6):1849–1865

219.

Wheeler TJ (1988) Translocation of glucose transporters in response to anoxia in heart. J Biol Chem 263(36):19447–19454PubMed

220.

Wold LE, Relling DP, Colligan PB, Scott GI, Hintz KK, Ren BH, Epstein PN, Ren J (2001) Characterization of contractile function in diabetic hypertensive cardiomyopathy in adult rat ventricular myocytes. J Mol Cell Cardiol 33(9):1719–1726PubMedCrossRef

221.

Wold LE, Ceylan-Isik AF, Fang CX, Yang X, Li SY, Sreejayan N, Privratsky JR, Ren J (2006) Metallothionein alleviates cardiac dysfunction in streptozotocin-induced diabetes: role of ca2+ cycling proteins, nadph oxidase, poly(adp-ribose) polymerase and myosin heavy chain isozyme. Free Radic Biol Med 40(8):1419–1429PubMedCrossRef

222.

Yang Z, Zingarelli B, Szabo C (2000) Effect of genetic disruption of poly (adp-ribose) synthetase on delayed production of inflammatory mediators and delayed necrosis during myocardial ischemia-reperfusion injury. Shock 13(1):60–66PubMedCrossRef

223.

Yazaki Y, Isobe M, Takahashi W, Kitabayashi H, Nishiyama O, Sekiguchi M, Takemura T (1999) Assessment of myocardial fatty acid metabolic abnormalities in patients with idiopathic dilated cardiomyopathy using 123i bmipp spect: correlation with clinicopathological findings and clinical course. Heart 81(2):153–159PubMed

224.

Ye G, Metreveli NS, Donthi RV, Xia S, Xu M, Carlson EC, Epstein PN (2004) Catalase protects cardiomyocyte function in models of type 1 and type 2 diabetes. Diabetes 53(5):1336–1343PubMedCrossRef

225.

Yim MB, Yim HS, Lee C, Kang SO, Chock PB (2001) Protein glycation: creation of catalytic sites for free radical generation. Ann N Y Acad Sci 928:48–53

226.

Yoon YS, Uchida S, Masuo O, Cejna M, Park JS, Gwon HC, Kirchmair R, Bahlman F, Walter D, Curry C, Hanley A, Isner JM, Losordo DW (2005) Progressive attenuation of myocardial vascular endothelial growth factor expression is a seminal event in diabetic cardiomyopathy: restoration of microvascular homeostasis and recovery of cardiac function in diabetic cardiomyopathy after replenishment of local vascular endothelial growth factor. Circulation 111(16):2073–2085PubMedCrossRef

227.

Young LH (2003) Insulin resistance and the effects of thiazolidinediones on cardiac metabolism. Am J Med 115(Suppl 8A):75S–80S

228.

Yusuf S, Dagenais G, Pogue J, Bosch J, Sleight P (2000) Vitamin e supplementation and cardiovascular events in high-risk patients. The heart outcomes prevention evaluation study investigators. N Engl J Med 342(3):154–160

229.

Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G (2000) Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The heart outcomes prevention evaluation study investigators. N Engl J Med 342(3):145–153

230.

Yusuf S, Gerstein H, Hoogwerf B, Pogue J, Bosch J, Wolffenbuttel BH, Zinman B (2001) Ramipril and the development of diabetes. JAMA 286(15):1882–1885PubMedCrossRef

231.

Zabalgoitia M, Ismaeil MF, Anderson L, Maklady FA (2001) Prevalence of diastolic dysfunction in normotensive, asymptomatic patients with well-controlled type 2 diabetes mellitus. Am J Cardiol 87(3):320–323PubMedCrossRef

232.

Zaman AK, Fujii S, Goto D, Furumoto T, Mishima T, Nakai Y, Dong J, Imagawa S, Sobel BE, Kitabatake A (2004) Salutary effects of attenuation of angiotensin ii on coronary perivascular fibrosis associated with insulin resistance and obesity. J Mol Cell Cardiol 37(2):525–535PubMedCrossRef

233.

Zarich SW, Arbuckle BE, Cohen LR, Roberts M, Nesto RW (1988) Diastolic abnormalities in young asymptomatic diabetic patients assessed by pulsed Doppler echocardiography. J Am Coll Cardiol 12(1):114–120PubMedCrossRef

234.

Zarich SW, Nesto RW (1989) Diabetic cardiomyopathy. Am Heart J 118(5 Pt 1):1000–1012

235.

Zeng G, Nystrom FH, Ravichandran LV, Cong LN, Kirby M, Mostowski H, Quon MJ (2000) Roles for insulin receptor, pi3-kinase, and akt in insulin-signaling pathways related to production of nitric oxide in human vascular endothelial cells. Circulation 101(13):1539–1545PubMed

236.

Zieman SJ, Kass DA (2004) Advanced glycation endproduct crosslinking in the cardiovascular System: potential therapeutic target for cardiovascular disease. Drugs 64(5):459–470PubMedCrossRef

Title: Diabetic cardiomyopathy: understanding the molecular and cellular basis to progress in diagnosis and treatment
Authors: Inês Falcão-Pires
Adelino F. Leite-Moreira
Publication date: 01-05-2012
Publisher: Springer US
Published in: Heart Failure Reviews / Issue 3/2012
Print ISSN: 1382-4147
Electronic ISSN: 1573-7322
DOI: https://doi.org/10.1007/s10741-011-9257-z

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The STEP trials

Springer Medicine

Diabetic cardiomyopathy: understanding the molecular and cellular basis to progress in diagnosis and treatment

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 3/2012

Angiogenic therapy for cardiac repair based on protein delivery systems

Animal models of cardiorenal syndrome: a review

Erythropoietin: a future therapy for failing hearts?

Intrinsic skeletal muscle alterations in chronic heart failure patients: a disease-specific myopathy or a result of deconditioning?

Role of various proteases in cardiac remodeling and progression of heart failure

The dilemma, causes and approaches to avoid recurrent hospital readmissions for patients with chronic heart failure

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page